glp-1 review and the kidney: from physiology to pharmacology and outcomes in diabetes What Happens After GLP-1 Weight
Description
Additionally, another robust randomized controlled trial found no association between semaglutide use and an increased risk of thyroid cancer [1]
Any consideration of GLP-1 therapy for binge eating should occur within a multidisciplinary framework , ideally involving input from psychiatry, dietetics, and specialist weight management services, with psychological support remaining central to treatment
The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) recommend integrating albuminuria assessment into routine care to enhance early detection, refine therapeutic decisions and improve prediction of long-term renal and cardiovascular outcomes [43,44,45]
Special considerations include pregnancy planning and perioperative management
